Interstitial and recruited macrophages prevent tuberculosis relapse by limiting immune evasion.

IF 8.3 1区 医学 Q1 MEDICINE, RESEARCH & EXPERIMENTAL
Valerie Vinette,Anthony Castro,Heather Kim,Carolina Trujillo,Min Xie,Martin Gengenbacher,Thomas R Ioerger,Sabine Ehrt
{"title":"Interstitial and recruited macrophages prevent tuberculosis relapse by limiting immune evasion.","authors":"Valerie Vinette,Anthony Castro,Heather Kim,Carolina Trujillo,Min Xie,Martin Gengenbacher,Thomas R Ioerger,Sabine Ehrt","doi":"10.1038/s44321-026-00432-6","DOIUrl":null,"url":null,"abstract":"Alveolar macrophages are the first immune cells to encounter Mycobacterium tuberculosis (Mtb) in the lungs, but they frequently fail to eliminate this pathogen, allowing Mtb to persist and replicate. Interstitial macrophages (IMs) are enlisted to restrict bacterial growth and limit immune evasion. While IMs have been implicated in controlling acute Mtb infection, their role during latent tuberculosis infection (LTBI) remains unexplored. To address this, we utilized a previously established mouse model of paucibacillary Mtb infection that recapitulates key aspects of human LTBI to deplete IMs during the latent phase. Depletion of IMs and recruited macrophages (RMs) led to TB relapse in 26% of mice compared to 2% in controls. Mice that relapsed exhibited an increased proportion of pro-inflammatory IMs and elevated concentrations of G-CSF, GM-CSF, IL-3, IL-12, IL-13, IL-17A, and KC in the lung. These findings demonstrate that IMs and RMs play a critical role in controlling latent Mtb and preventing TB relapse.","PeriodicalId":11597,"journal":{"name":"EMBO Molecular Medicine","volume":"21 1","pages":""},"PeriodicalIF":8.3000,"publicationDate":"2026-04-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"EMBO Molecular Medicine","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1038/s44321-026-00432-6","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"MEDICINE, RESEARCH & EXPERIMENTAL","Score":null,"Total":0}
引用次数: 0

Abstract

Alveolar macrophages are the first immune cells to encounter Mycobacterium tuberculosis (Mtb) in the lungs, but they frequently fail to eliminate this pathogen, allowing Mtb to persist and replicate. Interstitial macrophages (IMs) are enlisted to restrict bacterial growth and limit immune evasion. While IMs have been implicated in controlling acute Mtb infection, their role during latent tuberculosis infection (LTBI) remains unexplored. To address this, we utilized a previously established mouse model of paucibacillary Mtb infection that recapitulates key aspects of human LTBI to deplete IMs during the latent phase. Depletion of IMs and recruited macrophages (RMs) led to TB relapse in 26% of mice compared to 2% in controls. Mice that relapsed exhibited an increased proportion of pro-inflammatory IMs and elevated concentrations of G-CSF, GM-CSF, IL-3, IL-12, IL-13, IL-17A, and KC in the lung. These findings demonstrate that IMs and RMs play a critical role in controlling latent Mtb and preventing TB relapse.
间质和募集的巨噬细胞通过限制免疫逃避来预防结核病复发。
肺泡巨噬细胞是第一个在肺部遇到结核分枝杆菌(Mtb)的免疫细胞,但它们经常不能消除这种病原体,使结核分枝杆菌持续存在和复制。间质巨噬细胞(IMs)被用于限制细菌生长和限制免疫逃避。虽然IMs与控制急性结核分枝杆菌感染有关,但它们在潜伏性结核感染(LTBI)中的作用仍未被探索。为了解决这个问题,我们利用了先前建立的少杆菌性结核分枝杆菌感染小鼠模型,该模型概括了人类LTBI的关键方面,以在潜伏阶段消耗IMs。IMs和募集的巨噬细胞(RMs)耗竭导致26%的小鼠结核病复发,而对照组为2%。复发小鼠表现出促炎IMs比例增加,肺中G-CSF、GM-CSF、IL-3、IL-12、IL-13、IL-17A和KC浓度升高。这些发现表明,IMs和RMs在控制潜伏性Mtb和预防结核病复发方面发挥着关键作用。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
EMBO Molecular Medicine
EMBO Molecular Medicine 医学-医学:研究与实验
CiteScore
17.70
自引率
0.90%
发文量
105
审稿时长
4-8 weeks
期刊介绍: EMBO Molecular Medicine is an open access journal in the field of experimental medicine, dedicated to science at the interface between clinical research and basic life sciences. In addition to human data, we welcome original studies performed in cells and/or animals provided they demonstrate human disease relevance. To enhance and better specify our commitment to precision medicine, we have expanded the scope of EMM and call for contributions in the following fields: Environmental health and medicine, in particular studies in the field of environmental medicine in its functional and mechanistic aspects (exposome studies, toxicology, biomarkers, modeling, and intervention). Clinical studies and case reports - Human clinical studies providing decisive clues how to control a given disease (epidemiological, pathophysiological, therapeutic, and vaccine studies). Case reports supporting hypothesis-driven research on the disease. Biomedical technologies - Studies that present innovative materials, tools, devices, and technologies with direct translational potential and applicability (imaging technologies, drug delivery systems, tissue engineering, and AI)
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书